Share Twitter LinkedIn Facebook Email Arun Azad, Ph.D., MBBS, FRACP from Peter MacCallum Cancer Centre, discusses mHSPC Management, ESMO, Ongoing and Upcoming Clinical Trials in patients with metastatic hormone-sensitive prostate cancer.
Overview of SYNC-T Technology from Syncromune in Prostate Cancer Treatment – Charles Link, MD Prostate 2 Mins Read
Pioneering Advances in Non-Metastatic Prostate Cancer: Navigating ARPIs and Precision Diagnostics for Tailored Treatment [39 SLIDES] Prostate 5 Mins Read
Promontory Therapeutics: PT-112 triggers organelle stress and ribosomal inhibition Prostate 2 Mins Read